Following a decade of steady growth, use of bisphosphonates—medications that are effective for treating osteoporosis—declined in the United States by more than 50% from 2008 to 2012.
Jun 15, 2015
0
4
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UC San Francisco (UCSF).
Aug 11, 2014
0
0
Amgen Inc. said Tuesday that its second-quarter profit dipped 1 percent as higher spending on research, production and other items offset rising sales of its medicines.
Jul 30, 2013
0
0
(HealthDay)—Pfizer Inc. says it has gained U.S. approval for a drug designed to treat menopause-related hot flashes and potentially prevent osteoporosis in postmenopausal women who have a uterus.
Oct 4, 2013
0
0
Telephone motivational counseling sessions did not result in a statistically significant improvement in adherence to an osteoporosis medication regimen, according to a report published Online First by Archives of Internal ...
Feb 27, 2012
0
0
The International Osteoporosis Foundation (IOF) has published practical guidelines to assist clinicians in assessing treatment efficacy in patients who experience a fracture while on medication for osteoporosis.
Aug 31, 2012
1
0
A committee of Europe's medicines watchdog on Friday recommended suspending the use of an osteoporosis drug, saying the risks, including heart attacks, outweighed the benefits.
Jan 10, 2014
0
0
A review of more than a decade's worth of research on osteonecrosis of the jaw—when the bone in the jaw is exposed and begins to starve from a lack of blood—points to an increased risk for patients taking certain drugs ...
Dec 15, 2014
0
1
Doctors commonly recommend drug holidays, or breaks, from certain osteoporosis drugs due to the risks associated with these treatments. Yet little has been known about the ideal duration of the holidays and how best to manage ...
Jan 15, 2014
0
0
Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington ...
Feb 13, 2013
0
0
